TG and hematocrit: This observation supports previous studies that demonstrated many pathophysiological effects of thyroid hormones on the cardiovascular systems, and make it plausible that HT itself is not only a risk marker but rather a risk target that should be treated to decrease mortality and cardiovascular morbidities (7, 20).